For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
NSAIDs - Independent medicine & health information for consumers & professionals NSAIDs — medicine information
Latest independent drug information about NSAIDs and treatments, written and reviewed by experts in Australia.
NSAIDs are also known as nonsteroidal anti-inflammatory drugs or anti-inflammatories.
| Filter by audience: | |
|---|---|
| All | |
| Consumer | |
| Health professional | |
| Researchers & evaluators | |
| Members & stakeholders | |
| Other | |
| Title | Description | Type | Audience  |
Date* |
|---|---|---|---|---|
| Aspirin - Independent Australian health & medicines information | Learn all about aspirin, its use to relieve pain & fever, side effects, interactions & who should not take aspirin, including children younger than 16 years old | Web page | Consumers | 2012-05-11 00:00:00 |
| Ibuprofen for pain and fever - Independent Australian health & medicines information | Learn all about ibuprofen, its use to relieve pain or discomfort & fever, dosing, side effects, interactions & who should not take ibuprofen | Web page | Consumers | 2012-05-11 00:00:00 |
| Ibuprofen for fever - Independent Australian health & medicines information | Ibruprofen can be used if you have a fever after a vaccination. Learn about the active ingredient ibruprofen in brands such as Nurofen. This includes who can take it, side effects & possible interactions | Web page | Consumers | 2012-03-13 00:00:00 |
| Pain relievers explained | Even though non-prescription pain relievers are widely available, they are still medicines, and can have serious side effects. | Consumer publication - MedicinesTalk | Consumers | 2011-07-29 00:00:00 |
| What you need to know to complete the over-the-counter NSAIDs self-audit | Clinical audit used to assist pharmacists and pharmacy staff to review their recommendations of nonprescription NSAIDs against therapeutic guidelines and professional best practice standards. | Professional activity - Pharmacy Practice Review | Health Professionals | 2008-04-26 00:00:00 |
| Audit of provision of over-the-counter NSAIDs | Clinical audit used to assist pharmacists and pharmacy staff to review their recommendations of nonprescription NSAIDs against therapeutic guidelines. | Professional activity - Pharmacy Practice Review | Health Professionals | 2008-04-26 00:00:00 |
| Etoricoxib (Arcoxia): be aware of hypertension risk | Information about hypertension risk associated with use of the COX-2 selective NSAID etoricoxib (Arcoxia) | Professional publication - NPS RADAR - Brief item | Health Professionals | 2009-12-01 00:00:00 |
| Lumiracoxib (Prexige) for osteoarthritis | Reports urgent withdrawal of lumiracoxib by TGA because of serious liver adverse effects and includes review of lumiracoxib use for osteoarthritis. | Professional publication - NPS RADAR - Review | Health Professionals | 2006-08-01 00:00:00 |
| Indicators of Quality Prescribing: 16 | Indicators of Quality Prescribing: Indicator 16 Good Prescribing (Avoiding the ‘Triple Whammy’). This indicator asks practices how many patients are receiving a combination of ACE inhibitors (or angiotensin II-receptor antagonists), diuretics and NSAIDs (including COX-2 selective NSAIDs). | Professional tool - Indicators of quality prescribing | Health Professionals | 2006-02-01 00:00:00 |
| Case study PH4 report: For pharmacists. COX-2 selective NSAIDs | Patient with osteoarthritis, mild reflux and heart failure presents with increased joint pain previously well controlled with paracetamol. He asks about the new drug for arthritis. | Professional activity - Case study report | Health Professionals | 2002-02-01 00:00:00 |
| Case study 9 report: COX-2 selective NSAIDs | Patient with osteoarthritis, mild reflux and heart failure presents with recurrence of joint symptoms which were previously well controlled with paracetamol. | Professional activity - Case study report | Health Professionals | 2000-07-01 00:00:00 |
| Case study 17 report: COX-2 selective NSAIDs | Patient with osteoarthritis, mild reflux and heart failure presents with recurrence of joint symptoms which were previously well controlled with paracetamol. | Professional activity - Case study report | Health Professionals | 2001-10-01 00:00:00 |
| Case study PH4: For pharmacists. COX-2 selective NSAIDs | Patient with osteoarthritis, mild reflux and heart failure presents with increased joint pain previously well controlled with paracetamol. He asks about the new drug for arthritis. | Professional activity - Case study | Health Professionals | 2001-10-01 00:00:00 |
| Case Study 9 : COX-2-selective NSAIDs | Patient with osteoarthritis, mild reflux and heart failure presents with recurrence of joint symptoms which were previously well controlled with paracetamol | Professional activity - Case study report | Health Professionals | 2000-07-01 00:00:00 |
| Case study 17: COX-2 selective NSAIDs | Patient with osteoarthritis, mild reflux and heart failure presents with recurrence of joint symptoms which were previously well controlled with paracetamol. | Professional activity - Case study | Health Professionals | 2001-10-01 00:00:00 |
| NSAIDs: minimising the risk (insert) | Pharmacy letter insert with advice on appropriate use of NSAIDs to minimise risk to patients from their use. | Professional publication - Pharmacy Letter | Health Professionals | 2001-03-23 00:00:00 |
| Pain and analgesic options | Update on use of analgesics in chronic musculoskeletal pain, including patient selection for NSAIDs, opioids, pethidine, and tramadol. Includes case study. | Professional publication - NPS News | Health Professionals | 2006-08-01 00:00:00 |
| Dyspepsia and proton pump inhibitors | Reviews prescribing and patient counselling guidelines for proton pump inhibitors (PPIs) for dyspepsia, co-prescribing NSAIDS and gastroprotection. | Professional publication - NPS News | Health Professionals | 2006-06-01 00:00:00 |
| Analgesics and acute musculoskeletal pain | How to reduce the risk of harm resulting from analgesics treating acute musculoskeletal pain; COX-2 selective NSAIDs, paracetamol and opioid analgesics | Professional publication - NPS News | Health Professionals | 2003-06-01 00:00:00 |
| Osteoarthritis and COX-2 inhibitors | How safe are COX-2 selective NSAIDs in osteoarthritis? Are there adverse effects and drug interactions? What about glucosamine? | Professional publication - NPS News | Health Professionals | 2001-10-01 00:00:00 |
| NPS News 2: Pain management using anti-inflammatory drugs and herbs | Anti-inflammatory drugs (NSAIDs) and herbs used in managing pain. Discusses gastrointestinal complications reduced by misoprostol and includes a brief report on case study 1. | Professional publication - NPS News | Health Professionals | 1999-02-01 00:00:00 |
| NPS Prescribing Practice Review 16: COX-2 selective NSAIDs | Information on COX-2 selective NSAID prescribing when first listed on the PBS and their comparative adverse effect profile. Sample feedback prescribing data is also provided. | Professional publication - Prescribing Practice Review | Health Professionals | 2001-12-07 00:00:00 |
| NPS Prescribing Practice Review 22: Analgesics in musculoskeletal pain | Information on using pain assessment to guide analgesic choice and monitor effectiveness in musculoskeletal pain. Sample feedback prescribing data is also provided. | Professional publication - Prescribing Practice Review | Health Professionals | 2003-07-07 00:00:00 |
| Analgesics and persistent pain | Information on the use of paracetamol, NSAIDs, tramadol or opioids for persistent pain. Sample feedback prescribing data and PBS co-payment status of analgesics also provided. | Professional publication - Prescribing Practice Review | Health Professionals | 2006-09-01 00:00:00 |
| Elevated cardiovascular risk with NSAIDs? | Reviews evidence of elevated cardiovascular risk associated with COX-2 selective NSAIDs and provides guidelines for NSAID use and risk assessment. | Professional publication - NPS RADAR - Review | Health Professionals | 2005-08-01 00:00:00 |
| Articles on non-steroidal anti-inflammatory drugs (NSAIDS) from NPS RADAR | Get independent, accurate, evidence-based info on non-steroidal anti-inflammatory drugs (NSAIDS). Written for doctors, pharmacists & other health professionals. | Topic overview | Health Professionals | 2009-10-28 00:00:00 |
| NPS Prescribing Practice Review 22: Analgesics in musculoskeletal pain | Information on using pain assessment to guide analgesic choice and monitor effectiveness in musculoskeletal pain. Sample feedback prescribing data is also provided. | Professional publication - Prescribing Practice Review | Health Professionals | 2003-07-07 00:00:00 |
| Community Update 25 | This new Community Update includes information on NPS's fresh new look; new number for Medicines Line; Common colds resources; the latest edition of MedicinesTalk; using anti-inflammatory medicines safely and radio interviews with Dr John D’Arcy. | Consumer publication - Community Update | Consumers | 2010-07-16 00:00:00 |
| Be MedicineWise – talk to your doctor or pharmacist about NSAIDs | A study from Denmark into the safety of non-steroidal anti-inflammatory drugs (NSAIDs) has received significant media attention but the National Prescribing Service is concerned some media reports may exaggerate the risk of using these products. | Media release | Others | 2010-06-10 19:00:00 |
| Lumiracoxib (Prexige) for osteoarthritis | Since this issue of Medicine Update was published, lumiracoxib (Prexige) has been withdrawn by the Therapeutic Goods Administration. | Consumer publication - Medicine Update | Consumers | 2007-04-01 00:00:00 |
| Taking the pain out of choosing a painkiller | Learn about the three main over-the-counter analgesics (paracetamol, aspirin, and ibuprofen), their potential side effects, and how to select the best one. | Consumer publication - MedicinesTalk | Consumers | 2004-06-01 00:00:00 |
| NPS RADAR eases the pain of deciding on NSAID prescribing | The August issue of NPS RADAR lets pharmacists keep up to date with the debate on the use of NSAIDs including COX-2 inhibitors in treating inflammatory pain | Media release | Others | 2005-07-29 00:00:00 |
| NPS RADAR eases the pain of deciding on NSAID prescribing | The August issue of NPS RADAR lets GPs keep up to date with the debate on the use of NSAIDs including COX-2 inhibitors in treating inflammatory pain. | Media release | Others | 2005-07-29 00:00:00 |
| Paracetamol remains analgesic of choice | Health professional education program on the use of analgesics in persistent, non malignant pain (for trade press). | Media release | Others | 2006-08-15 00:00:00 |
| COX-2-selective NSAIDs: New wonder drugs? | A review of the physiology and pharmacology of the COX system, and published studies and clinical trials which have investigated the COX-2-selective NSAIDs. | Corporate publication - Research report | Research & Evaluation community | 2011-02-21 00:00:00 |
| Diclofenac and cardiovascular risk | Fact sheet reviewing the evidence for vascular risk associated diclofenac and other NSAIDs. | Media factsheet | Health Professionals,Others | 2006-09-15 00:00:00 |
| Pain management frequently asked questions | Pain management frequently asked questions | Campaign | Consumers | 2011-02-25 00:00:00 |
| Asthma | Asthma | Campaign | Consumers | 2011-02-25 00:00:00 |
| Anti-inflammatory medicines – definition written & reviewed by Australian experts | Anti-inflammatory medicines – medicines that are used to reduce inflammation. | Glossary item | Health Professionals,Consumers,Members & Stakeholders,Others,Research & Evaluation community | 2011-01-24 00:00:00 |
Information on this website is published by NPS — an independent, evidence based, not-for-profit organisation funded by the Australian Government Department of Health and Ageing.
NPS develops its information under the guidance of experts in their field, editorial panels, expert reviewers and consumers. Find out more about how we develop our content.
Date published: 2010-12-17 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
